Persistent poliovirus infection of human fetal brain cells

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 6395-6401

  Pavio, Nicole ^a   Buc Caron, Marie Hélène ^b   Colbère Garapin, Florence ^a  

^a INSTITUT PASTEUR   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN; FETUS; FETUS CELL; HUMAN; HUMAN CELL; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS STRAIN; VIRUS VIRULENCE;

EID: 0029817037     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.6395-6401.1996     Document Type: Article

References (42)

1. Agol, V., S. G. Drozdov, T. A. Ivannikova, M. S. Kolesnikova, M. B. Korolev, and E. A. Tolskaya. 1989. Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. J. Virol. 63:4034-4038.
2. Bentoa, P. A., J. W. Murphy,and R. E. Lloyd. 1995. K562 cell strains differ in their response to poliovirus infection. Virology 213:7-18.
3. Blondel, B., O. Akacem, R. Crainic, P. Couillin, and F. Horodniceanu. 1983. Detection by monocional antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions. Virology 126:707-710.
4. Blondel, B., R. Crainic, O. Fichot, G. Dufraisse, A. Candrea, D. Diamond, M. Girard, and F. Horaud. 1986. Mutations conferring resistance to neutralization with monocional antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J. Virol. 57:81-90.
5. Borzakian, S., I. Pelletier, V. Calvez, and F. Colbère-Garapin. 1993. Precise missense and silent point mutations are fixed in the genome of poliovirus mutants from persistently infected cells. J. Virol. 67:2914-2917.
6. Bottenstein, J. E., and G. Sato. 1979. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76:514-517.
7. Buc-Caron, M. H. 1995. Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro. Neurobiol. Dis. 2:37-47.
8. Calvez, V., I. Pelletier, S. Borzakian, and F. Colbère-Garapin. 1993. Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells. J. Virol. 67:4432-4435.
9. Calvez, V., I. Pelletier, T. Coudere, N. Pavio-Guédo, B. Blondel, and F. Colbère-Garapin. 1995. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants. Virology 212:309-322.
10. Calvez, V., I. Pelletier, N. Guédo, S. Borzakian, T. Couderc, B. Blondel, and F. Colbère-Garapin. 1995. Persistent poliovirus infection: development of new models with cell lines. Ann. N. Y. Acad. Sci. 753:370-373.
11. Carp, R. I. 1981. Persistent infection of human lymphoid cells with poliovirus and development of temperature sensitive mutants. Intervirology 15:49-56.
12. Colbère-Garapin, F., C. Christodoulou, R. Crainic, and I. Pelletier. 1989. Persistent poliovirus infection of human neuroblastoma cells. Proc. Natl. Acad. Sci. USA 86:7590-7594.
13. Colston, E. M., and V. R. Racaniello. 1995. Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J. Virol. 69:4823-4829.
14. Couderc, T., N. Guédo, V. Calvez, I. Pelletier, J. Hogle, F. Colbère-Garapin, and B. Blondel. 1994. Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice. J. Virol. 68:8386-8391.
15. Dalakas, M. C. 1986. New neuromuscuiar symtoms in patients with old poliomyelitis: a three year follow-up study. Eur. Neurology 25:381-387.
16. Dalakas, M. C. 1995. The post-polio syndrome as an evolved clinical entity. Definition and clinical description. Ann. N. Y. Acad. Sci. 753:68-80.
17. de la Torre, J. C., M. Davila, F. Sobrino, J. Ortin, and E. Domingo. 1985. Establishment of cell lines persistently infected with foot and mouth disease virus. Virology 145:24-35.
18. Eddé, B., H. Jakob, and M. Darmon. 1983. Two specific markers for neuronal differentiation of embryonai carcinoma cells. EMBO J. 2:1473-1478.
19. Fichot, O., and M. Girard. 1990. An improved method for sequencing RNA templates. Nucleic Acids Res. 18:6162.
20. Hellen, C. U. T., and E. Wimmer. 1995. Enterovirus genetics, p. 25-72. In H. A. Rotbart (ed.), Human enterovirus infections. ASM Press, Washington, D.C.
21. Hellen, C. U. T., and E. Wimmer. 1995. Enterovirus structure and assembly, p. 155-174. In H. A. Rotbart (ed.), Human enterovirus infections. ASM Press, Washington, D.C.
22. Hogle, J. M., M. Chow, and D. J. Filman. 1985. Three dimensional structure of poliovirus at 2.9 Å resolution. Science 229:1358-1365.
23. Holland, J. J. 1961. Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 15:312-326.
24. Iizuka, N., M. Kohara, K. Hagino-Yamagishi, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Construction of less neurovirulent polioviruses by introducing deletions into the 5′ noncoding sequence of the genome. J. Virol. 63:5354-5363.
25. Kuge, S., and A. Nomoto. 1987. Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5′ noncoding sequence in viral replication. J. Virol. 61:1478-1487.
26. La Monica, N., and V. R. Racaniello. 1989. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 63:2357-2360.
27. Lendahl, U., L. B. Zimmerman, and R. D. G. McKay. 1990. CNS stem cells express a new class of intermediate filament protein. Cell 60:585-595.
28. Leon-Monzon, M. E., and M. C. Dalakas. 1995. Detection of poliovirus antibodies and poliovirus genome in patients with the post-polio syndrome. Ann. N. Y. Acad. Sci. 753:208-218.
29. Leparc, I., H. Kopecka, F. Fuchs, I. Janatova, M. Aymard, and J. Julien. 1995. Search for poliovirus in specimens from patients with the post-polio syndrome. Ann. N. Y. Acad. Sci. 753:233-236.
30. Martin, A., C. Wychowski, T. Couderc, R. Crainic, J. Hogle, and M. Girard. 1988. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J. 7:2839-2847.
31. McAllister, A., F. Tanguy, C. Aubert, and M. Brahic. 1990. Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J. Virol. 64:4252-4257.
32. Minor, P. D., P. A. Pipkin, D. Hockley, G. C. Schild, and J. W. Almond. 1984. Monoclonal antibodies which block cellular receptors of poliovirus. Virus. Res. 1:203-212.
33. Morrison, M. E., Y. J. He, M. W. Wien, J. M. Hogle, and V. R. Racaniello. 1994. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 68:2578-2588.
34. Muir, P., F. Nicholson, M. K. Sharief, E. J. Thompson, N. J. Cairns, P. Lantos, G. T. Spencer, H. J. Kaminski, and J. E. Banatvala. 1995. Evidence for persistent enterovirus infection of the central nervous system in patients with previous paralytic poliomyelitis. Ann. N. Y. Acad. Sci. 753:219-232.
35. Murray, M. G., J. Bradley, X. F. Yang, E. Wimmer, E. G. Moss, and V. R. Racaniello. 1988. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site 1. Science 241:213-215.
36. Pelletier, I., T. Couderc, S. Borzakian, E. Wyckoff, R. Crainic, E. Ehrenfeld, and F. Colbère-Garapin. 1991. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology 180:729-737.
37. Pilipenko, E. V., A. P. Gmyl, S. V. Maslova, Y. V. Svitkin, A. N. Sinyakov, and V. I. Agol. 1992. Prokaryotic-like cis elements in the cap-independent internal initiation of translation on picornavirus RNA. Cell 68:119-131.
38. Raff, M. C., R. H. Miller, and M. Noble. 1983. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature (London) 303:390-396.
39. Sabaté, O., P. Horellou, E. Vigne, P. Colin, M. Perricaudet, M.-H. Buc-Caron, and J. Mallet. 1995. Transplantation to the rat brain of human neural progenitors which were genetically modified using adenoviruses. Nature Genet. 9:256-260.
40. Sharief, M. K., M. R. Hentges, and M. Ciardi. 1991. Intrathecal immune response in patients with the post-polio syndrome. N. Engl. J. Med. 325:749-755.
41. Tucker, R. P. 1990. The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Res. Rev. 15:101-120.
42. van der Werf, S., C. Wychowski, P. Bruneau, B. Blondel, R. Crainic, F. Horodniceanu, and M. Girard. 1983. Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1. Proc. Natl. Acad. Sci. USA 80:5080-5084.